Onanuga v. Pfizer, Inc.

369 F. Supp. 2d 491, 35 Employee Benefits Cas. (BNA) 1381, 2005 U.S. Dist. LEXIS 8983, 2005 WL 1140557
CourtDistrict Court, S.D. New York
DecidedMay 10, 2005
Docket03 CIV.5405 CM GAY
StatusPublished
Cited by11 cases

This text of 369 F. Supp. 2d 491 (Onanuga v. Pfizer, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Onanuga v. Pfizer, Inc., 369 F. Supp. 2d 491, 35 Employee Benefits Cas. (BNA) 1381, 2005 U.S. Dist. LEXIS 8983, 2005 WL 1140557 (S.D.N.Y. 2005).

Opinion

MEMORANDUM DECISION AND ORDER GRANTING THE MOTION OF DEFENDANT FOR SUMMARY JUDGMENT DISMISSING THE COMPLAINT AND DENYING THE MOTIONS OF BOTH PLAINTIFF AND DEFENDANT ON THE COUNTERCLAIM

MCMAHON, District Judge.

The following facts are undisputed: 1

Ebenzer Adebayo Onanuga (plaintiffs decedent) worked for 22 years at a Nigerian subsidiary of defendant Pfizer, Inc. The subsidiary was named Pfizer Products, LLC (formerly known as Pfizer Products Ltd.).

Pfizer Inc. and Pfizer Products LLC were at all times separate corporate entities. To avoid confusion — of which there is far too much in this record, most of it on plaintiffs part — defendant will be referred to hereinafter as “Inc” and the subsidiary will be referred to as “LLC.”

On May 14, 1997, Inc divested itself of its 60% shareholder ownership in LLC, selling out to the local management group of that company. Some of the employees of the subsidiary were reemployed by another Pfizer subsidiary, Pfizer Specialities Ltd. Most — including plaintiffs decedent— remained with Pfizer LLC. Thus, as of *494 May 14,1997, plaintiffs decedent ceased to have any affiliation with defendant.

At the time his employer ceased to be affiliated with Inc, plaintiffs decedent held options to purchase Pfizer stock. He was awarded these options in 1993, 1994, 1995 and 1996 pursuant to Inc’s Stock and Incentive Plan (“the Plan”). The terms of the stock options were governed by the Plan, which contained several pertinent provision relating to the lapsing of options. First, the Plan provided, as did each respective option award letter, that Onanu-ga’s options would lapse if he retired within one year following the date of the award. Assuming he remained employed for a year after each particular award, the Plan further provided that, “The option, to the extent not exercised, shall terminate ... when the optionee ceases to be an employee for any reason including retirement ... however ... if the option so provides, in the event that the optionee has retired or is eligible for retirement under Sections 4a., b., or d. or the Company’s Retirement Annuity Plan, as may be amended from time to time, or under any pension or retirement plan maintained by the Company or any of its subsidiaries, the optionee ... may elect to exercise the option at any time until such option expires by its terms .... ” The cited portions of the Pfizer Retirement Annuity Plan refer to “normal,” “ late,” and “early” retirement, respectively; the word “Company” refers to Inc.

As of the date LLC ceased to be an Inc subsidiary, plaintiffs decedent had not exercised many of his stock options. Nor did plaintiff exercise them within a week of May 14, 1997, pursuant to a special resolution of Inc’s Employee Compensation and Management Development Committee which administers the Plan, which had accelerated the vesting of all his unvested stock options and granted him (and other similarly situated employees of LLC) one additional week following the divestiture to exercise their options.

What did happen was this: On the same day that Inc divested itself of LLC — May 14, 1997 — plaintiffs decedent gave LLC, his employer, three months notice that he would be retiring effective August 14, 1997. The three months’ notice was required by the terms of Onanuga’s employment with LLC. Plaintiffs decedent thereafter worked for LLC — which soon changed its name to Neimeth International Pharmaceuticals (though for ease- of reference I will continue to call it “LLC”) — for the next three months. LLC accepted plaintiffs resignation, which took effect on August 14, 1997. LLC, which had retained the pension obligations under LLC’s Retirement Plan, was responsible for the payment of Onanuga’s pension. And less than a month after his retirement, LLC paid plaintiffs decedent his pension contribution, from LLC’s longstanding defined contribution pension plan, together with separation pay, less than a month after his retirement.

When the LLC employees who remained with that company were separated from Inc on May 14, 1997, Inc’s Human Relations Department coded Onanuga’s employment status in its database, coding him as “retired” instead of “separated.” As a result, plaintiffs decedent was actually able to exercise some of his options in March 1998; he realized almost $300,000 from that transaction. Onanuga did not exercise any other options prior to his death in 2001. He did continue to receive information about his stock option account from Merrill Lynch, which administered the Plan for Inc.

What Inc now describes as a “coding error” or “data entry error” was not discovered until January 2003, at which time plaintiff was attempting to exercise addi *495 tional stock options on behalf of her husband’s estate. By letter dated 30 April 2003, Inc notified the Onanuga family that the options had actually expired in May 1997. It also deactivated Onanuga’s stock option account at Merrill Lynch.

Plaintiff, Onanuga’s widow and executrix, now sues Inc for breaching its contract with her husband. Inc counterclaims for return of the $286,360 profit realized by Onanuga on the 1998 exercise of the ostensibly expired options. Inc has moved for summary judgment dismissing all of plaintiffs claims against it. Plaintiff has moved for summary judgment dismissing Inc’s counterclaim against her.

Summary of Argument

Notwithstanding the incredible amount of paper filed with the Court by both sides, the dispute is really quite simple. Both parties agree (plaintiff somewhat reluctantly) that the contract that was allegedly breached is the Plan. By its clear terms, the Plan provides that Onanuga’s stock options lapsed when he failed to exercise them by May 21, 1997. The only way around this rule would be if, prior to the time he “cease[d] to be a Company employee ...,” Onanuga either “has retired or [was] eligible for retirement under ... any pension or retirement plan maintained by the Company or any of its subsidiaries

Plaintiffs decedent was the Company Secretary of LLC, and a sophisticated businessman. It seems clear to this court that, by submitting his three months’ notice of intent to retire on the very day Inc spun off LLC, Onanuga was trying to bring himself within that exception to the usual rule. And indeed, plaintiff argues strenuously that “The message [plaintiffs decedent] wants this Court to hear is that he did not participate in the management buyout in 1997 either as an employee or owner of Neimeth [LLC], his employment with Pfizer was not terminated in 1997, and he neither worked nor retired from Neimeth [LLC], He retired from Pfizer after 23 years of outstanding contributions and dedicated service to Pfizer.” PI. Memorandum of Law at 23.

I have no doubt that plaintiffs decedent gave LLC (his employer) 23 years of outstanding contributions and dedicated service. However, Onanuga clearly had not retired as of May 14, 1997, when Inc spun off LLC. Indeed, he did not even submit his retirement papers until that day. Per the undisputed facts, his retirement was not effective until three months later, on August 14, and he continued to work for LLC for that three month period, drawing his regular compensation. One is not “retired” until one’s retirement is effective, and plaintiffs retirement was not effective until August 14, 1997.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

491 Bergen St. Corporation
S.D. New York, 2025
Sinanovic v. Wagner College
E.D. New York, 2022
Dist. Attorney of N.Y. Cnty. v. Republic of the Phil.
307 F. Supp. 3d 171 (S.D. Illinois, 2018)
Flo & Eddie, Inc. v. Sirius XM Radio, Inc.
62 F. Supp. 3d 325 (S.D. New York, 2014)
Angus Partners LLC v. Walder
52 F. Supp. 3d 546 (S.D. New York, 2014)
FAIVELEY TRANSPORT USA, INC. v. Wabtec Corp.
758 F. Supp. 2d 211 (S.D. New York, 2010)
Maxim Group LLC v. Life Partners Holdings, Inc.
690 F. Supp. 2d 293 (S.D. New York, 2010)
Roy v. General Electric Co.
544 F. Supp. 2d 103 (D. Rhode Island, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
369 F. Supp. 2d 491, 35 Employee Benefits Cas. (BNA) 1381, 2005 U.S. Dist. LEXIS 8983, 2005 WL 1140557, Counsel Stack Legal Research, https://law.counselstack.com/opinion/onanuga-v-pfizer-inc-nysd-2005.